Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
SV-BR-1-GM is a vaccine comprised of breast cancer cells from the cell line, SV-BR-1, and granulocyte-macrophage colony-stimulating factor, which may lead to an immune response against breast cancer cells (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cyclophosphamide + Interferon alpha-2b + Ipilimumab + SV-BR-1-GM||Cyclophosphamide Interferon alpha-2b Ipilimumab SV-BR-1-GM||0||1|
|Cyclophosphamide + Interferon alpha-2b + Pembrolizumab + SV-BR-1-GM||Cyclophosphamide Interferon alpha-2b Pembrolizumab SV-BR-1-GM||0||2|
|Cyclophosphamide + Interferon alpha-2b + SV-BR-1-GM||Cyclophosphamide Interferon alpha-2b SV-BR-1-GM||0||1|